Erratum: Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation

被引：0
|
作者：
A Venditti
L Maurillo
F Buccisano
G Del Poeta
C Mazzone
A Tamburini
M I Del Principe
M I Consalvo
P De Fabritiis
L Cudillo
A Picardi
A Franchi
F L Coco
S Amadori
机构：
来源：
Leukemia | 2004年 / 18卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Correction to: Leukemia (2003) 17, 2178–2182. doi:10.1038/sj.leu.2403138 It has been identified that one of the author names for this article was misspelled: FL Coco should in fact be F Lo-Coco.
引用
收藏
页码：373 / 373
相关论文
共 50 条
  • [1] Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation
    Venditti, A
    Maurillo, L
    Buccisano, F
    Del Poeta, G
    Mazzone, C
    Tamburini, A
    Del Principe, MI
    Consalvo, MI
    De Fabritiis, P
    Cudillo, L
    Picardi, A
    Franchi, A
    Coco, FL
    Amadori, S
    LEUKEMIA, 2003, 17 (11) : 2178 - 2182
  • [2] Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation
    A Venditti
    L Maurillo
    F Buccisano
    G Del Poeta
    C Mazzone
    A Tamburini
    M I Del Principe
    M I Consalvo
    P De Fabritiis
    L Cudillo
    A Picardi
    A Franchi
    F L Coco
    S Amadori
    Leukemia, 2003, 17 : 2178 - 2182
  • [3] Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation (vol 17, pg 2178, 2003)
    Venditti, A
    Maurillo, L
    Buccisano, F
    Del Poeta, G
    Mazzone, C
    Tamburini, A
    Del Principe, M
    Consalvo, M
    De Fabritiis, P
    Cudillo, L
    Picardi, A
    Franchi, A
    Coco, FL
    Amadori, S
    LEUKEMIA, 2004, 18 (02) : 373 - 373
  • [4] LONG TERM OUTCOME OF AUTOLOGOUS STEM CELL TRANSPLANTATION IN ADULT ACUTE MYELOID LEUKEMIA PATIENTS: THE ROLE OF MINIMAL RESIDUAL DISEASE
    Paolini, S.
    Romani, L.
    Ottaviani, E.
    Marconi, G.
    Papayannidis, C.
    Parisi, S.
    Sartor, C.
    Nanni, J.
    Cristiano, G.
    Abbenante, M. C.
    Talami, A.
    Olivi, M.
    Ragaini, S.
    Bandini, L.
    Venturi, C.
    Raffini, M.
    Robustelli, V.
    Martinelli, G.
    Testoni, N.
    Baldazzi, C.
    Cavo, M.
    Curti, A.
    HAEMATOLOGICA, 2019, 104 : 46 - 46
  • [5] Results of high dose chemotherapy and autologous stem cell transplantation in patients with acute myeloid leukemia.
    Ault, KA
    Case, DC
    Boyd, MA
    Ervin, TJ
    Aronson, FR
    Ebrahim, KS
    Hedlund, JA
    BLOOD, 2004, 104 (11) : 383B - 383B
  • [6] Results of high dose chemotherapy and autologous stem cell transplantation in patients with acute myeloid leukemia.
    Ault, Kenneth A.
    Case, Delvyn Caedren
    Boyd, Marjorie A.
    Ervin, Thomas J.
    Aronson, Frederick
    Ebrahim, Kurt S.
    Hedlund, Jacquelyn A.
    BLOOD, 2006, 108 (11) : 454B - 454B
  • [7] Therapy-related acute myeloid leukemia and myelodysplasia after high-dose chemotherapy and autologous stem cell transplantation
    Pedersen-Bjergaard, J
    Andersen, MK
    Christiansen, DH
    BLOOD, 2000, 95 (11) : 3273 - 3279
  • [8] High-dose idarubicin and busulphan as conditioning regimen to autologous stem cell transplantation in acute myeloid leukemia
    Ferrara, F
    Palmieri, S
    Annunziata, M
    Copia, C
    Pollio, F
    Mele, G
    BONE MARROW TRANSPLANTATION, 2002, 29 : S75 - S75
  • [9] Minimal Residual Disease Predicts the Outcome of Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia in the First Remission
    Konova, Zoya
    Parovichnikova, Elena
    Galtseva, Irina
    Kapranov, Nikolay
    Davydova, Julia
    Drokov, Mikhail
    Vasilyeva, Vera
    Kuzmina, Larisa
    Kulikov, Sergey
    Julhakyan, Hunan
    Savchenko, Valeriy
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S296 - S296
  • [10] Level of minimal residual disease after consolidation therapy predicts outcome in acute myeloid leukemia
    Venditti, A
    Buccisano, F
    Del Poeta, G
    Maurillo, L
    Tamburini, A
    Cox, C
    Battaglia, A
    Catalano, G
    Del Moro, B
    Cudillo, L
    Postorino, M
    Masi, M
    Amadori, S
    BLOOD, 2000, 96 (12) : 3948 - 3952
12345